Clinical Trials Browser

Phase 1/2 × cedazuridine × Dermatologic × Clear all

NCT05089370 2025-12-08

Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

Phase 1/2 Active not recruiting

Melanoma